⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
globenewswire.com
ATYR
Form 8-K
sec.gov
ATYR
aTyr Pharma Announces One-for-40 Reverse Stock Split
globenewswire.com
ATYR
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
globenewswire.com
ATYR
Form 8-K
sec.gov
ATYR
aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
globenewswire.com
ATYR
Efzofitimod Market Size and Commercial Potential 2026-2034 | Expanding Therapeutic Opportunities Drive Sales Outlook
globenewswire.com
ATYR
Form 8-K
sec.gov
ATYR
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
globenewswire.com
ATYR
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
globenewswire.com
ATYR